|
Vivian Berlin, Ph.D., Director of Business Development, Harvard
University Office of Technology Development
David Berry, MD, Ph.D., Partner, Flagship Ventures
Wesley D. Blakeslee, Executive Director, Technology Transfer,
Johns Hopkins University
Kristina Burow, Managing Director, ARCH Venture Partners
Margarita Chavez, Director, Venture Investments, Abbott Biotech
Ventures
Brenda Gavin, Founding Partner, Quaker Partners Management
Elizabeth Hart-Wells, Assistant Vice-President and Director,
Purdue Research Foundation
Yuji Iizawa, Ph.D., Vice President, Takeda Ventures
Raymond Jordt, Director, Corporate Business Development, Eli
Lilly
Nina Kjellson, General Partner, InterWest
David Lewin, Senior Associate Director of Licensing, Yale
University
Keith S. Marmer, DPT, MBA, Associate Dean for Research Innovation;
Director, Office of Technology Development, Penn State College of
Medicine
Dushyant Pathak, Associate Vice Chancellor, Technology Management &
Corporate Relations, UC Davis
Brendan Rauw, Associate Vice Chancellor and Executive Director of
Entrepreneurship, UCLA Office of Intellectual Property & Industry
Sponsored Research
Scott A. Siegel, Ph.D., Vice President, Business Development,
Ezose Sciences
Bill Thies, Ph.D., Chief Medical and Scientific Officer,
Alzheimer’s Association
...and many more!!!
For an updated speaker list,
click here.
Register today
and save up to $350!
Sign up
3 people for the price of 2!
Use discount code rcdvb.
|
For Business Development & Exhibiting Opportunities contact Maribel Cortes at
spex@gtcbio.com |
|
|
Upcoming Conferences
|
|
2nd Infectious Diseases World Summit
July 9-10, 2012, San Francisco, CA
9th Anti-Infectives Partnering & Deal-making
July 9-10, 2012, San Francisco, CA
10th Vaccines Research & Development:
All Things Considered
July 9-10, 2012, San Francisco, CA
Influenza Research and Development
July 9-10, 2012, San Francisco, CA
2nd CNS Diseases World Summit
September 13-14, 2012, San Francisco, CA
20% discount by July 13th
6th Neurdegenerative Conditions Research and Development
September 13-14, 2012, San Francisco, CA
20% discount by July 13th
2nd Neuropsychiatric Research and Development
September 13-14, 2012, San Francisco, CA
20% discount by July 13th
5th CNS Partnering and Deal-making
September 13-14, 2012, San Francisco, CA
20% discount by July 13th
Pain Research and Therapeutics
September 13-14, 2012, San Francisco, CA
20% discount by July 13th
3rd Biobased Chemicals: Commercialization & Partnering
September 13-14, 2012, San Francisco, CA
20% discount by July 13th
|
2nd Biomarker Europe Summit
September 5-7, 2012, Zurich, Switzerland
20% discount by July 5th
5th Oncology Biomarkers
September 5-6, 2012, Zurich, Switzerland
20% discount by July 5th
Neurological Biomarkers
September 6-7, 2012, Zurich, Switzerland
20% discount by July 5th
Inflammatory Biomarkers
September 6-7, 2012, Zurich, Switzerland
20% discount by July 5th
Drug Delivery Technologies & Formulation
September 5-6, 2012, Zurich, Switzerland
20% discount by July 5th
Modern Drug Discovery and Development (M3D) Summit
October 24-26, 2012, Philadelphia, PA
9th Stem Cell Research and Therapeutics
October 24-26, 2012, Philadelphia, PA
7th Assay and Drug Discovery Technologies
October 24-26, 2012, Philadelphia, PA
4th Translation Medicine
October 24-26, 2012, Philadelphia, PA
3rd Pharmacokinetics and Pharmacodynamics
October 24-26, 2012, Philadelphia, PA
3rd Cancer Immunotherapy and Immunomonitoring
(CITIM 2013)
April 22 - 25, 2013
Krakow, Poland, POL
|
|
This
advertisement is sent to !*EMAIL*! from GTC, 635 W. Foothill Blvd, Monrovia, CA 91016. If you prefer not to
receive further messages from this sender, please forward this email to
remove@gtcinsight.com or use the following link to unsubscribe
http://gtcbio.com/unsubscribe.php?emailid=!*EMAIL*! |
|